Skip to main content

Mazagon Dock Shipbuilders IPO day 3: Issue oversubscribed by 157 times, NII portion at 679 times

 Mazagon Dock is the only shipyard to build destroyers and conventional submarines to be used by the Indian Navy with a maximum shipbuilding and submarine capacity of 40,000 DW.

State-owned defence company Mazagon Dock Shipbuilders' initial public offering has seen strong demand since the day one. It is now subscribed 157.4 times so far on October 1, the last day of bidding, which was the highest subscription than Happiest Minds (151 times) this year.

The public issue has received bids for 481.5 crore equity shares against offer size of 3.06 crore equity shares, the data available on the exchanges showed.

The non-institutional investors increased their bids significantly on the final day as their reserved portion has oversubscribed by 679 times.

Retail investors have been active in bidding from the day one as the portion set aside for these investors has seen 35.5 times subscription.

The reserved portion of qualified institutional buyers witnessed 89.7 times subscription and that of employees 3.9 times.

Mazagon Dock is going to raise Rs 444 crore via public issue which consists of only offer for sale of 3,05,99,017 equity shares by the government. The issue included employees reserved portion of 3,45,517 equity shares.

"We believe Mazagon Dock IPO offer gives investors an opportunity to play on Indian growing defence story allied with Make in India push. We read out that it is the only company in the country to manufacture warships and submarines for the Indian Navy and also constructs cargo ships, multipurpose support vessels, dredgers and water tankers," Prashanth Tapse, AVP Research at Mehta Group told.

Most of bids so far seem to have received at higher end of price band of Rs 135-145 per share.

"On valuations parse at upper price band (Rs 145), the issue is asking for market capitalisation Rs 2,925 crore with PE (FY20) 6x compared to industry average of around 10x and P/BV below 1x versus industry average of around 1.52x, which seems to be fairly and reasonably prices with something left on the table for listing gains," Tapse said.

Considering attractive valuations and the objective of the issue which is to carry out the disinvestment of equity shares by the selling shareholder constituting 15.17 percent (offer for sale) paid up equity share capital, Tapse recommended investors to go a subscribe for listing gain.

Mazagon Dock Shipbuilders, with having a Mini Ratna status, was incorporated in 1934 as a private company which was later taken over by the government under warship development programme and is now India's leading defence PSU under Ministry of defence.

Company is primarily engaged in constructing and repairing warships and submarines and other types of vessels i.e. cargo ships, multipurpose support vessels, barges and border outposts, tugs, dredgers, water tankers, etc. for commercial clients.

It is the only shipyard to build destroyers and conventional submarines to be used by the Indian Navy with a maximum shipbuilding and submarine capacity of 40,000 DW.

As of now, it has built 795 vessels, including 25 warships, 4 missile boats, 3 submarines, 6 Leander class frigates, 3 Godavari class frigates, 3 Shivalik class frigates, 3 corvettes, and 6 destroyers.

Comments

Post a Comment

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...
Post a Comment
Read more

Taking Stock | Profit-booking pulls Nifty below 14,450; Sensex drops 549 points

  All the sectoral indices ended in the red with IT and PSU bank indices falling 2 percent each. The market remained under pressure on January 15 on the back of profit-booking across sectors amid weak global cues. At close, the Sensex was down 549.49 points or 1.11% at 49,034.67, and Nifty was down 161.90 points or 1.11% at 14,433.70. "The market witnessed profit-booking and following global trends. Nifty continues to resist 14,600 and has taken a dip towards 14,360. If the market closes below 14,380 levels, we might see a correction till the levels of 14,180-14,200. Momentum indicators like RSI, MACD are indicating a small correction in the markets," said Ashis Biswas, Head of Research at CapitalVia Global Research. All the sectoral indices ended in the red with IT and PSU bank falling 2 percent each. Broader markets performed in line with the main indices with BSE Midcap and Smallcap indices falling 1 percent each. Tech Mahindra, GAIL, HCL Tech, Wipro and ONGC...
Post a Comment
Read more

Similar to 2020, D-Street is at record high ahead of Budget 2021; will history repeat itself?

  Experts are of the view that a repeat of 2020 or what happened in March might not be possible but some consolidation cannot be ruled out. Back in March when everyone wanted to write-off 2020 from their books, hope and liquidity supported markets and investor sentiment. Nobody thought that after touching a 3-year low in March 2020, benchmark indices would give double-digit returns by the end of the year. The S&P BSE Sensex and Nifty50 rallied by about 15 percent in 2020 and the big outperformance came from the small and midcap stocks. The rally is still continuing in 2021. The S&P BSE Sensex, which climbed Mount 49K, is up over 3 percent while the Nifty50 is up over 4 percent so far in January. Sensex scaling the 49,000-mark and Nifty50 touching 14,500 levels ahead of the Budget 2021 could make anyone cautious about the strength of the rally. Back in January 2020, both Sensex and Nifty touched fresh highs ahead of Budget, and then the market fell like a pack of cards. The ...
Post a Comment
Read more